
Company Description
Vaxil BioTherapeutics is a clinical stage company developing a new class of synthetic therapeutic and preventive vaccines.
Vaxil BioTherapeutics Ltd. (TASE:VAXL), is a clinical stage company developing a new class of synthetic therapeutic and preventive vaccines with promiscuous antigen specific T and B-cell activation, based on its proprietary VaxHit technology.
-
Manufacturer:
Science and Engineering -
Company Website:
-
Company E-mail:
-
Company Address:
Bl 13A, 13 Einstein st., Weizmann Science ParkNess ZionaIsrael -
CEO:
- Julian Levy
-
We recognize our sponsors starting at $1 per entry.
Learn more at https://www.ithistory.org/benefits